Securing an updated coronavirus vaccine in 2025 presents unique challenges. The Food and Drug Administration's (FDA) approval criteria have focused the availability of these shots on specific populations. Currently, easy access is primarily limited to individuals aged 65 and older, and those with pre-existing conditions that significantly increase their risk of severe COVID-19 illness. This targeted approach, while aiming to protect the most vulnerable, leaves many questioning the accessibility of updated vaccines for the broader population. The restricted eligibility raises concerns about equitable distribution and the potential for widening health disparities. Further information regarding broader vaccine access and future FDA guidelines is crucial for ensuring the health and safety of the entire community. Staying informed about updates from official sources, such as the CDC and FDA websites, remains vital for all individuals seeking the most up-to-date information regarding vaccine availability and eligibility.
---
Originally published at: https://www.washingtonpost.com/health/2025/09/09/covid-vaccine-without-prescription-cdc/
